Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).
Conditions: Olfactory Neuroblastoma; Esthesioneuroblastoma; Neoplasm of the Nasal Cavity Intervention: Drug: Bintrafusp alfa / M7824 Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Cancer & Oncology | Esthesioneuroblastoma | Neuroblastoma | Neurology | Research | Study